PMD begins trading on Nasdaq Nordic following reverse acquisition

Cork medical devices firm holds 97.7% of the shares in Promore

Minister of State at the Department of Finance Jennifer Carroll MacNeill and Myles Murray, founder of Cork medical devices firm PMD, ringing the opening bell of the Nasdaq Stockholm Exchange. Picture: Nasdaq

Swedish biotechnology firm Promore Pharma has completed the reverse acquisition of Cork medical devices company, PMD Solutions.

The deal saw Promore purchase all shares in PMD for approximately €11m, which was paid by newly-issued shares in the Stockholm-based firm.